Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

8.5%

6 terminated/withdrawn out of 71 trials

Success Rate

82.4%

-4.2% vs industry average

Late-Stage Pipeline

1%

1 trials in Phase 3/4

Results Transparency

54%

15 of 28 completed trials have results

Key Signals

22 recruiting15 with results

Enrollment Performance

Analytics

N/A
44(73.3%)
Phase 2
9(15.0%)
Phase 1
5(8.3%)
Early Phase 1
1(1.7%)
Phase 3
1(1.7%)
60Total
N/A(44)
Phase 2(9)
Phase 1(5)
Early Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (71)

Showing 20 of 71 trials
NCT05050929Phase 2Active Not Recruiting

RAPid SimPLE Targeted Radiation Treatment for Brain Metastases

Role: collaborator

NCT06904365Recruiting

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

Role: collaborator

NCT05837767Not ApplicableRecruiting

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Role: collaborator

NCT06995053Not ApplicableActive Not Recruiting

Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial

Role: collaborator

NCT06108206Active Not Recruiting

Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma

Role: collaborator

NCT04221893Not ApplicableRecruiting

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Role: collaborator

NCT05785845Not ApplicableCompleted

Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer

Role: collaborator

NCT06077071Not ApplicableNot Yet Recruiting

Miami "RADAR" Trial

Role: collaborator

NCT05628363Not ApplicableActive Not Recruiting

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

Role: collaborator

NCT05802186Not ApplicableRecruiting

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

Role: collaborator

NCT06236516Not ApplicableCompleted

One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors

Role: collaborator

NCT05043857Not ApplicableActive Not Recruiting

Stereotactic PAncreatic RadioTherapy Adjuvant Therapy

Role: collaborator

NCT04682652Not ApplicableActive Not Recruiting

Genicular Artery Embolization Vs Observation for Symptomatic Knee Osteoarthritis

Role: collaborator

NCT04466683Phase 2Active Not Recruiting

Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia

Role: collaborator

NCT06071715Not ApplicableCompleted

Cryoanalgesia to Treat Phantom Limb Pain Following Above-Knee Amputation

Role: collaborator

NCT05112198Not ApplicableCompleted

Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer

Role: collaborator

NCT07276360Phase 2Recruiting

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

Role: collaborator

NCT05505643Not ApplicableRecruiting

Cryoablation vs Lumpectomy in T1 Breast Cancers

Role: collaborator

NCT06111313Phase 2Recruiting

The University of Miami Adapt (UAdapt) Trial

Role: collaborator

NCT05351424Not ApplicableRecruiting

AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc

Role: collaborator